Reversing Heart Disease: Combination of PCSK9 Inhibitors and Statins – Opinion by Steven Nissen, MD, Chairman of Cardiovascular Medicine at Cleveland Clinic Reporter: Aviva Lev-Ari, PhD, RN UPDATED on 2/25/2019 https://www.medpagetoday.com/cardiology/prevention/78202?xid=nl_mpt_SRCardiology_2019-02-25&eun=g99985d0r&utm_source=Sailthru&utm_medium=email&utm_campaign=CardioUpdate_022519&utm_term=NL_Spec_Cardiology_Update_Active While nearly 10% of middle-age adults in China have high risk for cardiovascular disease, only 0.6% of these high-risk individuals use statins and 2.4% […]
Search Results for 'Statins'
Reversing Heart Disease: Combination of PCSK9 Inhibitors and Statins – Opinion by Steven Nissen, MD, Chairman of Cardiovascular Medicine at Cleveland Clinic
Posted in Atherogenic Processes & Pathology, Frontiers in Cardiology and Cardiovascular Disorders, Origins of Cardiovascular Disease, PCSK9 Inhibitor Therapy, Pharmacotherapy of Cardiovascular Disease, Vascular Diseases, tagged Atherosclerosis, Cholesterol, LDL, PCSK9 inhibitors, statins on December 29, 2016| Leave a Comment »
Perioperative Statins at Noncardiac Surgery: Survival Up, Complications Down
Posted in Perioperative Statins at Noncardiac Surgery on December 27, 2016| Leave a Comment »
Perioperative Statins at Noncardiac Surgery: Survival Up, Complications Down Reporter: Aviva Lev-Ari, PhD, RN UPDATED on 11/26/2018 Clinical Trial: Statins Evaluation in Coronary Procedures and Revascularization (SECURE-PCI) A Cardio-Endo Connection selection by Dharam J. Kumbhani, MD, SM (Trial Summary); Deepak L. Bhatt, MD, MPH (Summary Reviewer) Contribution to Literature: The Statins Evaluation in Coronary […]
What’s the Story with Statins and Stroke Prevention? – A Q&A with Koto Ishida, MD – HCPLive
Posted in Uncategorized on January 30, 2015| Leave a Comment »
What’s the Story with Statins and Stroke Prevention? – A Q&A with Koto Ishida, MD HCPLive My patients are at high risk for future cardiovascular (CV) events; most have already had a stroke or a transient ischemic attack (TIA). Source: news.google.com See on Scoop.it – Cardiovascular and vascular imaging
Guideline Critics Shift Attacks From Beta Blockers To Statins – Forbes
Posted in Uncategorized on August 4, 2014| Leave a Comment »
Guideline Critics Shift Attacks From Beta Blockers To Statins Forbes With the release today of updated European and US guidelines the ongoing controversy regarding beta-blockers appears to be resolved. Source: http://www.forbes.com See on Scoop.it – Cardiovascular Disease: PHARMACO-THERAPY
Statins in Very Elderly Adults (Debate) – Medscape
Posted in Scoop.it on July 1, 2014| Leave a Comment »
Medscape Statins in Very Elderly Adults (Debate) Medscape It contrasted the effects of intensive statin therapy with those of moderate statin therapy on reduction of myocardial ischemia in participants.
Statins cut limb events in PAD patients – Family Practice News Digital Network
Posted in Uncategorized on September 16, 2013| Leave a Comment »
See on Scoop.it – Cardiovascular and vascular imaging Statins cut limb events in PAD patients Family Practice News Digital Network “This is one of the first, and largest, studies to demonstrate an impact [of statin treatment] on adverse limb outcomes in patients with PAD, including worsening… See on http://www.familypracticenews.com
Advantages and Disadvantages of Novel Oral Anticoagulants (NOACs)
Posted in Coagulation Therapy and Internal Bleeding, tagged Apixaban, Dabigatran, edoxaban, Novel Oral Anticoagulants (NOACs), Rivaroxaban on March 20, 2018| Leave a Comment »
Advantages and Disadvantages of Novel Oral Anticoagulants (NOACs) Reporter: Aviva Lev-Ari, PhD, RN UPDATED ON 2/1/2019 NOACs Usually Preferable to Warfarin in Atrial Fibrillation: Guideline Update READ ALL GUIDELINES at the sources listed below. Here we post only, Triple vs Double Antithrombotic Therapy The update provides a warning about the extra bleeding […]
FDA approval on 12/1/2017 of Amgen’s evolocumb (Repatha) a PCSK9 inhibitor for the prevention of heart attacks, strokes, and coronary revascularizations in patients with established cardiovascular disease
Posted in Atherogenic Processes & Pathology, Frontiers in Cardiology and Cardiovascular Disorders, Origins of Cardiovascular Disease, PCSK9 Inhibitor Therapy, Pharmacotherapy of Cardiovascular Disease on December 1, 2017| Leave a Comment »
FDA approval on 12/1/2017 of Amgen’s evolocumb (Repatha) a PCSK9 inhibitor for the prevention of heart attacks, strokes, and coronary revascularizations in patients with established cardiovascular disease Reporter: Aviva Lev-Ari, PhD, RN Evolocumab was first FDA approved in 2015 for patients with familial hypercholesterolemia and others who fail to achieve LDL cholesterol lowering through diet and […]
Advertisements
-
Recent Posts
- Tweets, Pictures and Retweets at 18th Annual Cancer Research Symposium – Machine Learning and Cancer, June 14, 2019, MIT by @pharma_BI and @AVIVA1950 for #KIsymposium PharmaceuticalIntelligence.com and Social Media June 16, 2019
- Featuring Computational and Systems Biology Program at Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute (SKI), The Dana Pe’er Lab June 16, 2019
- Can Elelphants Help Fight Cancer? June 16, 2019
- New ways to Heal Damage after a Heart Attack June 14, 2019
- Optimization of CRISPR Gene Editing with Gold Nanoparticles June 13, 2019
- Healing Powers of Fibrinogen June 13, 2019
- Breakthrough in Gene Editing CRISPR–Cas systems: First example of a fully programmable, RNA-guided integrase and lays the foundation for genomic manipulations that obviate the requirements for double-strand breaks and homology-directed repair. June 13, 2019
- Laboratory for Genomics Research (LGR) to be established by GSK ($67M investment in 5 years) at UC, Berkeley/UCSF to be lead by Prof. Jennifer Doudna focusing on immunology, oncology, and neuroscience disease-causing gene mutations and development of new technologies using CRISPR to accelerate new drug discovery June 13, 2019
- Alternative to CRISPR/Cas9 – CAST (CRISPR-associated transposase) – A New Gene-editing Approach for insertion of Large DNA Sequences into a Genome developed @BroadInstitute @MIT @Harvard June 11, 2019
- First Surgical Robot Making Surgeon’s Life More Efficient June 10, 2019
Archives
Categories
Meta
-
2012pharmaceutical
-
Aashir Awan, Phd
-
Alan F. Kaul, PharmD., MS, MBA, FCCP
-
alexcrystal6
-
amnondanzig1724
-
anamikasarkar
-
apreconasia
-
aviralvatsa
-
David Orchard-Webb, PhD
-
danutdaagmailcom
-
Demet Sag, Ph.D., CRA, GCP
-
Dror Nir
-
evelinacohn
-
Gail S Thornton
-
Irina Robu
-
jdpmd
-
kellyperlman
-
Ed Kislauskis
-
larryhbern
-
lmulligan13gmailcom
-
marzankhan
-
megbaker58
-
pkandala
-
Rosalind Codrington, PhD
-
ritusaxena
-
Rick Mandahl
-
sjwilliamspa
-
stuartlpbi
-
Dr. Sudipta Saha
-
tildabarliya
-
zraviv06
-
zs22
-
Advertisements
